Close
Novotech

News

SBI Pharma and Chugai Enter an Agreement of Exclusive Marketing Rights for ALAGLIO Granule 1.5g Japan

SBI Pharmaceuticals Co., Ltd. , a subsidiary of SBI Holdings, Inc., engaged in the research and development of medicines using 5-ALA*. (5-Aminolevulinic acid), has entered a licensing agreement with Chugai Pharmaceutical Co., Ltd. to grant Chugai...

CordenPharma Wins 2017 Life Science Leader CMO Leadership Awards Across All Award Categories

CordenPharma, a full-service Contract Development & Manufacturing Organization , will be awarded 2017 CMO Leadership Awards presented by Life Science Leader magazine across all 6 Core Award Categories and all 8 Specialty Award Categories. There are...

Taking the strain out of cancer diagnosticsย 

Rainin electronic pipettes are helping California-based Clarient Diagnostic Services, Inc. to provide cancer diagnostic testing. Flow cytometry supervisor Brian Ngo explained: โ€œOur laboratory uses flow cytometry to detect specific biomarkers that help to diagnose leukaemia, and...

Patheon Named Supply Chain Resiliency Partner Of The Year

Patheon N.V. ,a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma sectors, announced that the company was selected as the winner of the โ€œSupply Chain Resiliency Partner of the Yearโ€ award by...

eRegulatory Summit – Expert Speaker Post

Join the experts at this year's eRegulatory Summit for all the latest industry updates, regulatory advice, practical guidance & ample case studies for benchmarking strategies in 3 key areas:ย  ย  Regulatory Information Management & IDMP...

Clintec marks 20th year of global clinical research with launch of new brand

Clintec announces the launch of its new brand identity โ€“ reflected in their newly created website. This in part marks Clintecโ€™s 20th anniversary and the achievement of significant milestones following another year of substantial growth, together with a succession...

GW Pharmaceuticals Achieves Positive Results in Phase 2 Proof of Concept Study in Glioma

GW Pharmaceuticals plc , a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform. GW Pharmaceuticalsย announced positive top-line results from an exploratory Phase 2 placebo-controlled clinical study of a...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป